TEVA
Teva Pharmaceutical Industries
PEG ratio, current and historical analysis
- Stocks
- Healthcare
- NYSE: TEVA
- PEG Ratio
TEVA currently has a PEG ratio reading of 0.11 as of Jun 22, 2026. This value reflects a P/E ratio of 23.5 measured against EPS growth of 220.2%.
TEVA PEG ratio history
A six years lookback shows an average PEG ratio of 2.17 for Teva Pharmaceutical Industries. Compared to historical data, TEVA's 0.11 PE to growth ratio represents a decline of 95%. TEVA reached its maximum PEG ratio of 12.29 during the Jun 2020 quarter over the past six years. The Mar 2026 quarter had the bottom reading at 0.1, indicating the most optimal growth-adjusted valuation.
Teva Pharmaceutical Industries PEG ratio by year
| Year | PEG ratio | PE ratio | Growth YoY |
|---|---|---|---|
| 2025 | 0.14 | 25.37 | 184.8% |
| 2024 | N/A | N/A | -190% |
| 2023 | N/A | N/A | 77.3% |
| 2022 | N/A | N/A | -678.9% |
| 2021 | 0.19 | 21.08 | 110.4% |
| 2020 | N/A | N/A | -300% |
| 2019 | N/A | N/A | 61.3% |
| 2018 | N/A | N/A | 85.5% |
| 2017 | N/A | N/A | -23,328.6% |
| 2016 | N/A | 517.86 | -96.2% |
| 2015 | N/A | 35.67 | -48.6% |
| 2014 | 0.11 | 16.06 | 140.3% |
| 2013 | N/A | 26.9 | -33.8% |
| 2012 | N/A | 16.6 | -27.4% |
| 2011 | N/A | 13.02 | -16.7% |
Teva Pharmaceutical Industries PEG ratio by quarter (TTM)
| Year | PEG ratio | PE ratio | Growth YoY |
|---|---|---|---|
| Mar 2026 | 0.1 | 21.99 | 220.2% |
| Dec 2025 | 0.14 | 25.37 | 184.8% |
| Sep 2025 | 0.18 | 32.06 | 174.1% |
| Jun 2025 | N/A | N/A | 65% |
| Mar 2025 | N/A | N/A | -165.1% |
| Dec 2024 | N/A | N/A | -190% |
| Sep 2024 | N/A | N/A | 59.5% |
| Jun 2024 | N/A | N/A | 81% |
| Mar 2024 | N/A | N/A | 72.1% |
| Dec 2023 | N/A | N/A | 77.3% |
| Sep 2023 | N/A | N/A | -81% |
| Jun 2023 | N/A | N/A | -122.1% |
| Mar 2023 | N/A | N/A | -180% |
| Dec 2022 | N/A | N/A | -678.9% |
| Sep 2022 | N/A | N/A | -275.8% |
TEVA average PEG ratio chart
Measured against past performance, TEVA's PEG ratio is below the 5 and 10-year averages.
PEG comparison
Teva Pharmaceutical Industries's PEG of 0.11 is below the Healthcare sector and the industry average. Compared to its Healthcare sector average of 0.55, Teva Pharmaceutical Industries's PEG is 80% lower.
TEVA EPS growth
TEVA Price vs fair value
TEVA PEG vs peers
TEVA has a PEG ratio below that of peer stocks NVS and AZN.
| Stock name | PEG ratio | Market cap |
|---|---|---|
| TEVA Teva Pharmaceutical Industries Ltd | 0.11 | $37.49B |
| AZN Astrazeneca plc | 0.78 | $273.29B |
| NVS Novartis AG | 2.31 | $284.17B |
| PFE Pfizer Inc | N/A | $142.94B |
| MRK Merck & Co Inc | N/A | $285.22B |
Frequently asked questions
What is Teva Pharmaceutical Industries's PEG ratio?
According to Jun 22, 2026 data, TEVA's PEG ratio sits at 0.11.
What is the 5-year average PEG ratio for Teva Pharmaceutical Industries (TEVA)?
Over the last 5 years, TEVA's PEG ratio has settled near 0.15.
What is the highest PEG ratio for TEVA?
TEVA's PEG ratio peaked at 12.29 during the Jun 2020 quarter - the highest in six years.
How does the current PEG ratio for TEVA compare to its historical average?
Currently, TEVA's PEG ratio stands 95% lower than its 6-year historical average.
Why is Teva Pharmaceutical Industries's PEG ratio so low?
At 0.11, TEVA's PEG ratio suggests the stock may be attractively priced given its growth rate.
How is TEVA's PEG ratio calculated (Teva Pharmaceutical Industries PEG ratio formula)?
Computing the PEG ratio involves dividing the PE ratio by the company's EPS growth (YoY TTM). As of Jun 22, 2026, Teva Pharmaceutical Industries has a P/E ratio of 23.5. Earnings grew at 220.2% over the TTM period ending Mar 2026. Applying the formula, this produces a price to earnings growth ratio of 0.11. PEG RATIO(0.11) = PE RATIO(23.5) / EPS GROWTH(220.2%)
All PEG ratio stats are based on quarterly TTM periods, unless otherwise specified.